• SENSEX 78,009.25
    -70.71 (--0.09%)
  • BANKNIFTY 57,491.10
    -144.15 (--0.25%)
  • ICICI Pru Life
    511.95 706.50(%)
  • HDFC Bank
    729.65 1,020.35(%)
  • Apollo Hospitals
    8,925.00 9,326.80(%)
  • Wework India
    700.00 419.60(%)
  • LG Electronics
    1,736.35 1,736.40(%)
  • Gland Pharma
    3,039.00 3,039.00(%)
  • Bharti Airtel
    2,005.65 2,174.70(%)
  • Leap India
    143.10 143.10(%)
  • Blue Star
    1,497.00 1,450.00(%)
  • Cupid
    288.00 32.76(%)
  • Netweb Technol.
    4,995.00 2,037.65(%)
  • Honasa Consumer
    509.90 509.90(%)
  • Manorama Indust.
    1,867.00 1,867.00(%)
  • Vodafone Idea
    14.17 15.35(%)
  • Technocraft Ven.
    334.60 334.60(%)
  • Bharat Dynamics
    1,420.00 1,655.25(%)
  • Dixon Technolog.
    14,210.00 18,471.50(%)
  • Billionbrains
    194.60 112.02(%)
  • Infosys
    1,159.00 984.00(%)
  • Gujarat Fluoroch
    4,897.00 4,959.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

ANG Lifesciences India Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 70392.0
  • ISIN : INE236W01016
31.42 0 (0.00%)
  • As on 15 Aug 2026 (EOD)

  • Today’s Low

    31.42

  • Today’s High

    31.55

  • Open

    31.42

  • Perv Close

    31.42

  • 52W Low

    17.63

  • 52W High

    49.69

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    41.03

  • Div & Yield %

    0.00

  • Book Value(₹)

    47.65

  • Debt-Equity Ratio

    0.00

  • AGM Date

    14-Aug-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.88

  • Mar.Cap (₹Cr.)

    41.03

  • RONW (%)

    -10.56

  • ROCE (%)

    1.43

Score Board

  • Equity (₹ in Cr.)

    13.06

  • BV (₹)

    47.60

  • Sales( ₹ in Cr.)

    91.60

  • NP (in Cr.)

    -4.73

  • NP Var(%)

    52.0

  • Div%

    0.0

  • CPS (₹)

    1.00

  • EPS (₹)

    -3.60

  • Traded Value (₹ in Lakhs)

    41.03

  • 52 Week High

    49.69

  • 52 Week Low

    17.63

  • Price BSE

    31.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    41.03

  • P/C Ratio

    29.90

  • P/E Ratio

    -8.60

  • Price Vs.BV

    -3.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 89.91 131.37 207.01 348.67 154.28 126.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 89.91 131.37 207.01 348.67 154.28 126.83
Other Income 2.44 0.84 9.84 0.95 0.75 0.42
Stock Adjustments 3.39 6.74 4.22 4.47 4.30 0.59
Total Income 95.74 138.95 221.07 354.09 159.33 127.84
EXPENDITURE :            
Raw Materials 63.98 93.93 151.12 234.49 108.26 89.56
Power and Fuel Cost 3.25 3.61 5.99 5.68 4.88 3.66
Employee Cost 14.45 15.90 20.27 18.32 14.35 7.10
Other Manufacturing Expenses 1.36 0.91 1.85 2.96 1.60 1.03
Selling and Administration Expenses 10.58 13.04 18.21 23.49 13.56 10.60
Miscellaneous Expenses 1.15 2.89 2.12 2.65 0.59 3.04
Employee Benefit Expenses 14.45 15.90 20.27 18.32 14.35 7.10
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 94.77 130.28 199.56 287.60 143.24 114.99
Operating Profit 0.97 8.66 21.51 66.49 16.08 12.85
Interest 7.64 9.77 10.92 8.31 3.98 3.22
Gross Profit -6.67 -1.11 10.59 58.18 12.10 9.63
Depreciation 6.27 7.75 8.52 5.12 2.24 1.23
Profit Before Tax -12.94 -8.86 2.07 53.06 9.86 8.40
Current Tax 0.00 0.00 2.11 13.47 3.18 2.40
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.59 -0.22 0.62 -0.11 -0.57 -0.09
Reported Net Profit -10.34 -8.65 -0.66 39.71 7.25 6.10
Extraordinary Items -0.45 -1.56 -0.27 0.00 0.00 0.00
Adjusted Net Profit -9.89 -7.09 -0.39 39.71 7.25 6.10
Adjustment below Net Profit 0.08 0.19 0.72 0.21 -0.70 -0.26
P & L Balance brought forward 59.02 63.16 63.10 24.22 17.67 13.03
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 -4.33 0.00 1.04 0.00 0.00
P & L Balance carried down 48.76 59.02 63.16 63.10 24.22 18.87
Dividend 0.00 0.00 0.00 1.04 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 10.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 1.00 0.00 0.00
Earnings Per Share-Unit Curr -7.92 -6.62 -0.51 38.31 13.99 11.76
Earnings Per Share(Adj)-Unit Curr -7.92 -6.62 -0.51 30.65 5.60 4.70
Book Value 50.88 58.74 61.91 76.00 76.99 66.67
Book Value(Adj)-Unit Curr 50.88 58.74 61.91 60.80 30.80 26.67

Shareholding Pattern

  • Promoter Group

    70.60%

  • Public Share Holding

    29.40%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,219,537 70.60 9,219,537 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,219,537 70.60 9,219,537 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 29,142 0.22 29,142 20
Clearing Members 1,305 0.01 1,305 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 247,334 1.89 247,334 68
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 136,848 1.05 136,848 92
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 892,623 6.84 892,623 20
Individuals holding nominal share capital up to Rs. 1 lakh 2,529,331 19.37 2,524,781 5,745
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,167 0.02 2,167 1
Sub Total 3,838,750 29.40 3,834,200 5,950
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,058,287 100.00 13,053,737 5,952

Company Background

ANG Lifesciences India LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • ANG Lifesciences India Ltd
  • BSE Code : 70392.0
  • ISIN : INE236W01016

  • Incorporation Year

    2006

  • Registered Office

    Darbara Complex SCO 113 I Flr
    Dist. Shopping Centre B Block, Amritsar,
    Punjab-143001

  • Telephone

    91-0183-5070118/5070119

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Harshita Aggarwal

  • Auditor

    Khurana Sharma & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    E-2/3 Ansa Indl Est,
    Saki Vihar Road ,Sakinaka Andheri(E)
    Mumbai - Mumbai - 400072

ANG Lifesciences India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
ANG Lifesciences 31.42 92.35 89.91 -8.68 -3.80
Abbott India 27,076.90 7,217.19 6,929.05 35.63 43.78
Astrazeneca Phar 7,753.70 2,304.07 2,275.58 114.28 27.86
Glaxosmi. Pharma 2,689.10 3,932.76 3,790.20 42.96 58.17
Novartis India 1,586.70 398.23 356.27 40.07 16.64
Cipla 1,450.00 20,102.60 18,979.95 38.11 13.88
Bliss GVS Pharma 524.05 773.53 729.81 48.66 12.51
Amrutanjan Healt 494.75 469.50 451.82 26.50 21.89
Fermenta Biotec. 449.40 474.15 450.25 20.98 18.77
Guj. Themis Bio. 349.05 152.47 150.80 78.09 27.21
Ambalal Sarabhai 42.47 19.52 3.94 78.65 6.77